MuscleTech Performance Series naNOX9 Next Gen
Natural health product licensed in Canada
- Licence holder
- Iovate Health Sciences International Inc.
- NPN or DIN-HM
- 80071643
- Status
- Active licence
- Licence date
- 3 August 2016
- Revision date
- 8 January 2018
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Niacine Source : Niacine | 7.5 milligramme | Not calculated |
| Panax ginseng Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 50 milligramme Potency : 5 % Total ginsenosides | 12.5 milligramme | Not calculated |
| Acide (S)-2-amino-5-[(aminoiminométhyl)amino]pentanoïque Source : Arginine silicate inositol | 142.5 milligramme | Not calculated |
| Eleutherococcus senticosus Source : Racine | 25 milligramme | Not calculated |
| Crataegus laevigata Source : Fruit | 37.5 milligramme | Not calculated |
| Choline Source : Bitartrate de choline | 10.25 milligramme | Not calculated |
| Acide 3-aminopropanoïque Source : Beta-alanine | 400 milligramme | Not calculated |
| Punica granatum Source : Fruit | 25 milligramme | Not calculated |
| Rhodiola rosea Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 250 milligramme | 25 milligramme | Not calculated |
Non-medicinal ingredients
Carboxyméthylcellulose de sodium, Hydroxypropylcellulose, Macrogol 3350, Rouge FD&C N° 40, Silice, Acide stéarique, Stéarate de magnésium, Talc, Cellulose microcristalline, Phosphate de dicalcium dihydraté, Acésulfame potassium, Poly(alcool vinylique), Laque d'aluminium bleu FD&C n° 1, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 4 Comprimé | 1 day |
Uses authorised in Canada
Helps to increase arginine and nitric oxide levels. Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps the body to metabolize carbohydrates, proteins and fats.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
May cause a flushing, tingling and/or prickling sensation of the skin, in which case, reduce the dose. Consult a health care practitioner if symptoms persist or worsen. If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you are taking antidepressant medication, consult a health care practitioner prior to use. If you are taking hormone replacement therapy (HRT) or birth control pills, consult a health care practitioner prior to use. People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient. Ensure to drink enough fluid before, during, and after exercise. Consult a health care practitioner prior to use if you are taking cardiac glycosides such as digitalis/digoxin, or blood pressure medication. Consult a health care practitioner prior to use if you have any type of acute infection. Do not use if you have high blood pressure. Consult a health care practitioner if your cardiovascular condition worsens. Consult a health care practitioner prior to use if you suffer from a cardiovascular disease and are attempting an increase in physical activity. Consult a health care practitioner prior to use if you have a renal/kidney disease or if you are following a low protein diet. Consult your health care practitioner prior to use if you are taking medication for cardiovascular diseases, erectile dysfunction, and/or blood thinners. Some people may experience gastrointestinal discomfort (such as diarrhea).
- Contre-indications
If you have bipolar disorder or bipolar spectrum disorder, do not use this product. Do not use if you have had a heart attack/myocardial infraction.
- Effets indésirables connus
If you experience irritability or insomnia, discontinue use.
Source
Official Health Canada record, licence 80071643
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging